Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-CIF
NCT07483736Phase 3Not yet recruiting
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Mar 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amoxicillin + clavulanate in fever, sponsored by Centre Hospitalier de Versailles. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
amoxicillin + clavulanate
03
Conditions
fever
Beyond the preview
Go deeper on NCT07483736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07483736.